Frederick R. Appelbaum

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

Also affiliated with University of Washington, Fred Hutch Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 24 papers. Top paper: “Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial”.

Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial

Blood Advances(2020)10.1182/bloodadvances.2020002904

N/A

1.5DataRank · unranked

61 citations

Richard A. Larson, Dan Jones, Guido Marcucci, Thomas W. Prior, Jürgen Krauter +32 more

Evidence generation and reproducibility in cell and gene therapy research: A call to action

Molecular Therapy - Methods & Clinical Development(2021)10.1016/j.omtm.2021.06.012

N/A

0.934DataRank · unranked

24 citations

Aris Angelis, Frederick R. Appelbaum, Nancy C. Andrews, Susan E. Bates, Arlene S. Bierman +33 more

Conditioning Intensity, Pre-Transplant Flow Cytometric Measurable Residual Disease, and Outcome in Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

Cancers(2020)10.3390/cancers12092339

N/A

0DataRank · unranked

41 citations

Brenda M. Sandmaier, Megan Othus, Raffaele Palmieri, Noa Granot, Evandro D. Bezerra +10 more

Outpatient intensive induction chemotherapy for acute myeloid leukemia and high-risk myelodysplastic syndrome

Blood Advances(2020)10.1182/bloodadvances.2019000707

N/A

0DataRank · unranked

28 citations

Kelda M. Gardner, Kathleen Shannon Dorcy, Andrea Perdue, Heather Smith, Alicyn M. Davis +12 more

Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid Leukemia

JCO Oncology Practice(2020)10.1200/jop.19.00133

N/A

0DataRank · unranked

23 citations

Megan Othus, Guillermo Garcia‐Manero, Min Fang, Jerald P. Radich, David A. Rizzieri +24 more

A phase II trial evaluating the efficacy of high‐dose Radioiodinated Tositumomab (Anti‐CD20) antibody, etoposide and cyclophosphamide followed by autologous transplantation, for high‐risk relapsed or refractory non‐hodgkin lymphoma

American Journal of Hematology(2020)10.1002/ajh.25818

N/A

0DataRank · unranked

10 citations

Joseph G. Rajendran, Darrell R. Fisher, Frederick R. Appelbaum, Ryan D. Cassaday, Paul S. Martin +8 more

Association of immunophenotype with expression of topoisomerase II α and β in adult acute myeloid leukemia

Scientific Reports(2020)10.1038/s41598-020-62345-9

N/A

0DataRank · unranked

4 citations

Shannon McDonough, Cheryl L. Willman, Eric R. Koegle, John E. Godwin, Stephen H. Petersdorf +8 more

AML Risk Stratification Models Utilizing ELN-2017 Guidelines and Additional Prognostic Factors: A SWOG Report

Research Square(2020)10.21203/rs.3.rs-24023/v1

N/A

0DataRank · unranked

3 citations

Anna Moseley, Megan Othus, Frederick R. Appelbaum, Thomas R. Chauncey, I-Ming L. Chen +17 more

Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results

Leukemia(2021)10.1038/s41375-021-01323-0

N/A

0DataRank · unranked

90 citations

Ling Du, Tamara J. Luck, Axel Benner, Julia Krzykalla, Insa Gathmann +25 more

Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR

Leukemia(2021)10.1038/s41375-021-01213-5

N/A

0DataRank · unranked

42 citations

Wendy Stock, Anjali S. Advani, Selina M. Luger, Richard A. Larson, Martin S. Tallman +22 more

Tipifarnib as maintenance therapy did not improve disease-free survival in patients with acute myelogenous leukemia at high risk of relapse: Results of the phase III randomized E2902 trial

Leukemia Research(2021)10.1016/j.leukres.2021.106736

N/A

0DataRank · unranked

6 citations

Victoria X. Wang, Jacob M. Rowe, Mark R. Litzow, Elisabeth Paietta, Rhett P. Ketterling +11 more

Predicting severe toxicities with intensive induction chemotherapy for adult acute myeloid leukemia: analysis of SWOG Cancer Research Network trials S0106 and S1203

Leukemia & lymphoma/Leukemia and lymphoma(2021)10.1080/10428194.2021.1881512

N/A

0DataRank · unranked

2 citations

Megan Othus, Guillermo Garcia‐Manero, Frederick R. Appelbaum, Harry P. Erba, Roland B. Walter +1 more

Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial

Leukemia(2022)10.1038/s41375-022-01650-w

N/A

0DataRank · unranked

39 citations

Maral Saadati, Lars Bullinger, Richard A. Larson, Tiziana Ottone, Sergio Amadori +18 more

Relative impact of residual cytogenetic abnormalities and flow cytometric measurable residual disease on outcome after allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia

Haematologica(2022)10.3324/haematol.2022.281585

N/A

0DataRank · unranked

27 citations

Jacob A. Wilson, Min Fang, Brenda M. Sandmaier, Eduardo Rodríguez‐Arbolí, Brent L. Wood +4 more

Contribution of measurable residual disease status to prediction accuracy of relapse and survival in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation

Haematologica(2022)10.3324/haematol.2022.281631

N/A

0DataRank · unranked

21 citations

Megan Othus, Corentin Orvain, Lucas C. Zarling, Brenda M. Sandmaier, Filippo Milano +7 more

Relationship Between Pretransplantation Nutritional Status and Outcome in Adults with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.09.023

N/A

0DataRank · unranked

15 citations

Mariia Byelykh, Megan Othus, Brenda M. Sandmaier, Gary Schoch, Chris Davis +3 more

Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients

Biomarker Research(2023)10.1186/s40364-023-00461-0

N/A

0DataRank · unranked

4 citations

Xing Hua, Megan Othus, Frederick R. Appelbaum, Thomas R. Chauncey, Harry P. Erba +14 more

Examining the impact of age on the prognostic value of ELN-2017 and ELN-2022 acute myeloid leukemia risk stratifications: a report from the SWOG Cancer Research Network

Haematologica(2023)10.3324/haematol.2023.282733

N/A

0DataRank · unranked

2 citations

Anna Moseley, Megan Othus, Frederick R. Appelbaum, Thomas R. Chauncey, Harry P. Erba +10 more

Impact of socioeconomic disparities on outcomes in adults undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukemia

Leukemia(2024)10.1038/s41375-024-02172-3

N/A

0DataRank · unranked

12 citations

Megan Othus, Corentin Orvain, Eduardo Rodríguez‐Arbolí, Filippo Milano, Brenda M. Sandmaier +6 more

Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with MDS/AML or AML

American Journal of Hematology(2024)10.1002/ajh.27259

N/A

0DataRank · unranked

8 citations

Naveed Ali, Megan Othus, Eduardo Rodríguez‐Arbolí, Filippo Milano, Calvin M. Le +5 more

Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Adult Acute Myeloid Leukemia: Outcomes and Prognostic Factors

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.06.019

N/A

0DataRank · unranked

7 citations

Megan Othus, Corentin Orvain, Naveed Ali, Filippo Milano, Chris Davis +6 more

Probability of remission with reinduction with 7+3 versus high-dose cytarabine: analysis of SWOG trial S1203

Leukemia(2025)10.1038/s41375-024-02512-3

N/A

0DataRank · unranked

0 citations

Guillermo Garcia‐Manero, Frederick R. Appelbaum, Harry P. Erba, Eliana Dietrich, Suravi Raychaudhuri +4 more

Treatment discontinuation due to toxicity for patients with acute myeloid leukemia receiving intensive chemotherapy

Blood Neoplasia(2025)10.1016/j.bneo.2025.100129

N/A

0DataRank · unranked

0 citations

Megan Othus, Mary‐Elizabeth M. Percival, Guillermo Garcia‐Manero, Frederick R. Appelbaum, Harry P. Erba +2 more

Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003–2007 Versus 2013–2017 Cohorts

Annals of Internal Medicine(2020)10.7326/m19-2936

N/A

0DataRank · unranked

278 citations

Brenda M. Sandmaier, Marco Mielcarek, Mohamed L. Sorror, Steven A. Pergam, Guang‐Shing Cheng +11 more